What Are Peptides? How They Work & Their Therapeutic Uses

The Short Answer

A peptide is a short chain of amino acids — the same building blocks that make up proteins. The difference is size: proteins are long, complex molecules, while peptides are smaller and more targeted. Most peptides contain between 2 and 50 amino acids linked together in a specific sequence.

Your body already produces hundreds of peptides naturally. Insulin is one. So is oxytocin. These molecules act like biological messengers — they signal cells to do specific things, whether that's release a hormone, repair tissue, or trigger an immune response. Therapeutic peptides work by mimicking or amplifying those natural signals.

How Peptides Work in the Body

Think of peptides as keys and cell receptors as locks. When the right peptide binds to the right receptor, it flips a switch inside the cell. That switch might tell the pituitary gland to release growth hormone, prompt a muscle cell to start rebuilding, or encourage a fat cell to release stored energy.

This specificity is a big part of why peptides attract clinical interest. A well-designed peptide can target one pathway without broadly disrupting others — at least in theory. Research is still ongoing for many compounds, and results in humans don't always mirror what's seen in early lab studies.

Because peptides are made of amino acids, the body can break them down and clear them relatively quickly. That's one reason many therapeutic peptides are delivered by injection rather than taken orally — stomach acid and digestive enzymes tend to degrade them before they can absorb into the bloodstream.

Where Therapeutic Peptides Come From

Some peptide therapies are FDA-approved drugs. Semaglutide, for example, is an approved GLP-1 receptor agonist used for type 2 diabetes and obesity. Tirzepatide is another approved option in the same general category.

Many other peptides discussed in clinical wellness and anti-aging circles are compounded — meaning they are custom-prepared by licensed compounding pharmacies and are not FDA-approved as finished drug products. These include peptides like BPC-157, CJC-1295, and sermorelin. Compounded peptides exist in a complicated regulatory space; some have been subject to FDA scrutiny and restrictions. Always work with a licensed physician before pursuing any peptide therapy.

The Main Therapeutic Categories

Clinics that offer peptide therapy generally group their protocols around a handful of goals. Here's how the categories break down:

Growth Hormone Support

Several peptides stimulate the pituitary gland to produce and release more growth hormone (GH). These are called growth hormone secretagogues (GHS) or growth hormone-releasing peptides (GHRPs).

• Sermorelin is a synthetic version of growth hormone-releasing hormone (GHRH) and was previously FDA-approved for diagnosing GH deficiency in children.
• Ipamorelin is a selective GHRP often described as having a cleaner side-effect profile than older compounds in its class.
• CJC-1295 is a longer-acting GHRH analog frequently combined with ipamorelin in clinical protocols.
• Tesamorelin is FDA-approved specifically for reducing excess abdominal fat (lipodystrophy) in HIV patients, though it's sometimes prescribed off-label.

Clinics may use these for goals related to anti-aging, muscle growth, and hormone optimization.

Weight Management

GLP-1 receptor agonists — including semaglutide and tirzepatide — are among the most studied peptide-based therapies available today. They regulate appetite, slow gastric emptying, and influence insulin secretion. Both are approved drugs with substantial clinical trial data behind them. They're also among the most commonly prescribed therapies for weight loss at peptide-focused clinics.

Recovery and Tissue Repair

BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from a protein found in gastric juice. Animal studies suggest it may support tendon healing, reduce inflammation, and protect gut tissue — but robust human clinical trials are limited. It is not FDA-approved. Clinics offering BPC-157 typically position it around athletic recovery and injury rehabilitation.

Sexual Health

PT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system rather than the vascular system, distinguishing it from medications like sildenafil. It is FDA-approved under the brand name Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women, and is also used off-label for men. Clinics often offer it in the context of sexual health protocols.

What to Expect at a Peptide Clinic

A reputable clinic will start with bloodwork and a thorough intake consultation before recommending any peptide protocol. The prescribing physician should review your health history, existing medications, and goals. Protocols are typically monitored with follow-up labs.

When researching clinics, look for:

• Licensed physicians (MD, DO, NP, or PA) overseeing prescriptions
• Transparent sourcing — peptides dispensed from licensed compounding pharmacies
• Clear explanations of what is and isn't FDA-approved
• Willingness to discuss risks alongside potential benefits

The Bottom Line

Peptides are a diverse class of molecules with a wide range of clinical applications. Some — like semaglutide and tesamorelin — are backed by robust clinical evidence and carry FDA approval. Others are compounded or still in early research phases, meaning the evidence base is thinner and the regulatory status is less certain. Neither category is inherently good or bad; the right question is always whether a specific therapy is appropriate for a specific person.

If you're curious about peptide therapy, the best starting point is a conversation with a qualified provider. Browse our directory to find a clinic near you.

---

This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy.